83 Long-term efficacy and safety outcomes of the modified (simplified) combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) as front-line therapy for unresectable or metastatic urothelial cancer (UC)

✍ Scribed by Necchi, A.; Mariani, L.; Giannatempo, P.; Raggi, D.; Fare', E.; Pizzocaro, G.; Piva, L.; Biasoni, D.; Torelli, T.; Catanzaro, M.; Stagni, S.; Milani, A.; Gianni, A.; De Braud, F.; Nicolai, N.; Salvioni, R.

• Book ID: 122670444
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 70 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)60575-8